Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
9.59
+0.39 (4.24%)
Apr 30, 2026, 4:00 PM EDT - Market closed
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.44 billion as of April 30, 2026. Its market cap has decreased by -23.85% in one year.
Market Cap
1.44B
Enterprise Value
1.41B
1-Year Change
-23.85%
Ranking
Category
Stock Price
$9.59
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.44B, an increase of 451.47%. That is a compound annual growth rate of 60.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 1.44B | -3.71% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.46B |
| Immunocore Holdings | 1.46B |
| Damora Therapeutics | 1.46B |
| Agios Pharmaceuticals | 1.45B |
| Wave Life Sciences | 1.45B |
| Bicara Therapeutics | 1.44B |
| Maze Therapeutics | 1.43B |
| Precigen | 1.42B |